About Us
Overview
Leadership
Scientific Advisory Board
Technology
Overview
Transpo-mAb™
SMAC-Technology™
PNU anthracycline payload
Immune Oncology
Publications
Pipeline
News & Events
News
NBE Therapeutics in the News
Events
Contact
Join Our Team
Home
About Us
Overview
Leadership
Scientific Advisory Board
Technology
Overview
Transpo-mAb™
SMAC-Technology™
PNU anthracycline payload
Immune Oncology
Publications
Pipeline
News & Events
News
NBE Therapeutics in the News
Events
Contact
Join Our Team
News
NBE Therapeutics in the News
Events
News
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Select a year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
December 13 - NBE-Therapeutics closes extension of seed financing and conversion into a Swiss AG (Ltd.)
Read more
October 15 - NBE-Therapeutics has been awarded and is coordinating a € 1.4 mio European "Research for SMEs" grant
Read more
June 3 - NBE-Therapeutics has been awarded a CHF 1.0 mio grant of the Swiss Commission for Technology and Innovation (CTI) for an ETH collaboration
Read more
April 14 - NBE-Therapeutics featured in national newspaper "NZZ am Sonntag"
Read more
January 31 - Seed financing obtained by Boehringer Ingelheim Venture Fund (BIVF)
Read more